Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BMGL NASDAQ:EUDA NASDAQ:KDLY NASDAQ:NAKA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBMGLBasel Medical Group$1.98+4.2%$2.22$0.91▼$9.40$35.06MN/A150,203 shs142,471 shsEUDAEUDA Health$2.60+7.0%$3.14$2.06▼$6.30$90.36M-0.0669,040 shs24,861 shsKDLYKindly MD$10.63+5.4%$11.87$0.65▼$34.77$64.01MN/A2.29 million shs341,021 shsNAKAKindlyMD$10.13-4.7%$11.80$0.65▼$34.77$4.00B34.35670,741 shs470,851 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBMGLBasel Medical Group-2.06%-7.32%-13.64%+38.69%+189,999,900.00%EUDAEUDA Health+17.96%-6.54%-19.54%-35.37%-48.52%KDLYKindly MD-4.99%-23.85%-7.85%-57.75%+483.24%NAKAKindlyMD+5.35%-29.23%-4.83%+1,062,999,900.00%+1,062,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBMGLBasel Medical GroupN/AN/AN/AN/AN/AN/AN/AN/AEUDAEUDA HealthN/AN/AN/AN/AN/AN/AN/AN/AKDLYKindly MDN/AN/AN/AN/AN/AN/AN/AN/ANAKAKindlyMDN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBMGLBasel Medical Group 0.00N/AN/AN/AEUDAEUDA Health 4.00Strong BuyN/AN/AKDLYKindly MD 0.00N/AN/AN/ANAKAKindlyMD 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBMGLBasel Medical GroupN/AN/AN/AN/AN/AN/AEUDAEUDA Health$4.01M24.09N/AN/A($0.07) per share-37.14KDLYKindly MD$2.47M25.91N/AN/AN/A∞NAKAKindlyMD$2.72M1,400.77N/AN/A$0.02 per share506.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBMGLBasel Medical GroupN/AN/A0.00∞N/AN/AN/AN/AN/AEUDAEUDA Health-$15.36MN/A0.00N/AN/AN/AN/AN/AN/AKDLYKindly MDN/A-$0.77N/A∞N/AN/AN/AN/AN/ANAKAKindlyMD-$3.62M-$0.860.00∞N/A-244.00%-131.09%-106.04%N/ALatest BMGL, NAKA, EUDA, and KDLY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025NAKAKindlyMDN/A-$0.34N/A-$0.35N/A$0.41 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBMGLBasel Medical GroupN/AN/AN/AN/AN/AEUDAEUDA HealthN/AN/AN/AN/AN/AKDLYKindly MDN/AN/AN/AN/AN/ANAKAKindlyMDN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBMGLBasel Medical GroupN/AN/AN/AEUDAEUDA HealthN/A0.180.15KDLYKindly MDN/A5.435.42NAKAKindlyMDN/A13.0013.00Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBMGLBasel Medical GroupN/AEUDAEUDA Health4.35%KDLYKindly MDN/ANAKAKindlyMDN/AInsider OwnershipCompanyInsider OwnershipBMGLBasel Medical GroupN/AEUDAEUDA HealthN/AKDLYKindly MD50.50%NAKAKindlyMD40.79%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBMGLBasel Medical Group3618.45 millionN/AN/AEUDAEUDA Health237.16 millionN/ANot OptionableKDLYKindly MDN/A6.02 million2.96 millionN/ANAKAKindlyMDN/A376.12 million4.47 millionN/ABMGL, NAKA, EUDA, and KDLY HeadlinesRecent News About These CompaniesKindlyMD (NAKA) & Its Peers Critical ReviewAugust 22 at 3:07 AM | americanbankingnews.comKindlyMD Appoints Tim Pickett as Chief Medical OfficerAugust 21 at 8:00 AM | accessnewswire.comANakamoto Holdings Expands Bitcoin Hoard to 5,765 BTC in Major AcquisitionAugust 19 at 12:52 PM | news.bitcoin.comKindlyMD Acquires 5,744 BTC to Expand Nakamoto Bitcoin TreasuryAugust 19 at 8:00 AM | accessnewswire.comAHead to Head Contrast: KindlyMD (NASDAQ:NAKA) and Premier (NASDAQ:PINC)August 19 at 2:17 AM | americanbankingnews.comKindlyMD Closes $200 Million Convertible Note OfferingAugust 15, 2025 | accessnewswire.comAKindlyMD Announces Uplisting to the Nasdaq Global MarketAugust 15, 2025 | accessnewswire.comAKindlyMD Completes Merger with Nakamoto to Establish Bitcoin TreasuryAugust 14, 2025 | accessnewswire.comANakamoto Holdings Appoints Amanda Fabiano as Chief Operating OfficerAugust 6, 2025 | accessnewswire.comAKindlyMD (NASDAQ:NAKA) Announces Quarterly Earnings ResultsAugust 6, 2025 | marketbeat.comKindly MD Reports Financial Results for Second Quarter 2025August 5, 2025 | accessnewswire.comAKindlyMD and Nakamoto Announce the Filing of the Definitive Information Statement in Connection with Proposed MergerJuly 22, 2025 | businesswire.comYZi Labs Announces Support for 10X Capital's BNB Treasury Company in the U.S.July 9, 2025 | globenewswire.comKindlyMD Raises Another $51.5M for Bitcoin Treasury StrategyJune 20, 2025 | coindesk.comKindlyMD and Nakamoto Announce an Additional $51.5 Million In PIPE Financing To Support Bitcoin Treasury EffortsJune 20, 2025 | businesswire.comNakamoto Holdings Appoints Tyler Evans as Chief Investment Officer to Lead Bitcoin-Native Capital DeploymentJune 18, 2025 | businesswire.comNakamoto Holdings to Participate in ICR Conference Spotlight SeriesJune 17, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBMGL, NAKA, EUDA, and KDLY Company DescriptionsBasel Medical Group NASDAQ:BMGL$1.98 +0.08 (+4.21%) As of 04:00 PM EasternBasel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.EUDA Health NASDAQ:EUDA$2.60 +0.17 (+7.00%) Closing price 04:00 PM EasternExtended Trading$2.56 -0.04 (-1.73%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.Kindly MD NASDAQ:KDLY$10.63 +0.54 (+5.35%) As of 08/21/2025Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT.KindlyMD NASDAQ:NAKA$10.13 -0.50 (-4.70%) As of 04:00 PM EasternKindly MD, Inc. (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. Through its focus on an embedded model of prescriber and therapist teams, KindlyMD develops patient-specific care programs with a specific mission to reduce opioid use in the patient population while successfully treating patients with effective and evidence-based non-opioid alternatives in close conjunction with behavioral therapy. Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The Company captures all relevant datapoints to assist and appropriately treat each individual patient. This also results in valuable data for the Company and the Company’s investors. We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America. Business Revenue Streams We currently earn revenue through (i) patient care services related to medical evaluation and treatment and (ii) product retail sales. Our forecasted plan is to operate across various revenue streams: (i) medical evaluation and treatment visits reimbursed by Medicare, Medicaid, and commercial insurance payers as well as self-pay services, (ii) data collection and research, (iii) education partnerships, (iv) service affiliate agreements, and (v) retail sales. Our principal executive offices are located at 5097 S 900 E, Suite 100 Salt Lake City, UT. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot 3 Reasons Salesforce Is a Bargain Right Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access